BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38175391)

  • 1. Epidemiology of gastroenteropancreatic neuroendocrine neoplasms: a review and protocol presentation for bridging tumor registry data with the Italian association for neuroendocrine tumors (Itanet) national database.
    Panzuto F; Partelli S; Campana D; de Braud F; Spada F; Cives M; Tafuto S; Bertuzzi A; Gelsomino F; Bergamo F; Marcucci S; Mastrangelo L; Massironi S; Appetecchia M; Filice A; Badalamenti G; Bartolomei M; Amoroso V; Landoni L; Rodriquenz MG; Valente M; Colao A; Isidori A; Fanciulli G; Bollina R; Ciola M; Butturini G; Marconcini R; Arvat E; Cinieri S; Berardi R; Baldari S; Riccardi F; Spoto C; Giuffrida D; Gattuso D; Ferone D; Rinzivillo M; Bertani E; Versari A; Zerbi A; Lamberti G; Lauricella E; Pusceddu S; Fazio N; Dell'Unto E; Marini M; Falconi M
    Endocrine; 2024 Apr; 84(1):42-47. PubMed ID: 38175391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Pavel M; Öberg K; Falconi M; Krenning EP; Sundin A; Perren A; Berruti A;
    Ann Oncol; 2020 Jul; 31(7):844-860. PubMed ID: 32272208
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine neoplasms in a Chinese population: a large, retrospective single-centre study.
    Zhang M; Zhao P; Shi X; Zhao A; Zhang L; Zhou L
    BMC Endocr Disord; 2017 Jul; 17(1):39. PubMed ID: 28705205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent epidemiology of patients with gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NEN) in Japan: a population-based study.
    Masui T; Ito T; Komoto I; Uemoto S;
    BMC Cancer; 2020 Nov; 20(1):1104. PubMed ID: 33189127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chinese expert consensus on gastroenteropancreatic neuroendocrine neoplasms (2022 edition)].
    Expert Committee on Neuroendocrine Neoplasms, Chinese Society of Clinical Oncology
    Zhonghua Zhong Liu Za Zhi; 2022 Dec; 44(12):1305-1329. PubMed ID: 36575783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Consensus and controversy of endoscopic diagnosis and treatment of gastroenteropancreatic neuroendocrine tumors].
    Chen H; Chen Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):982-986. PubMed ID: 28900987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and treatment of gastroenteropancreatic neuroendocrine tumors: current data on a prospectively collected, retrospectively analyzed clinical multicenter investigation.
    Niederle MB; Niederle B
    Oncologist; 2011; 16(5):602-13. PubMed ID: 21467149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastroenteropancreatic Neuroendocrine Tumors.
    Fernandes CJ; Leung G; Eads JR; Katona BW
    Gastroenterol Clin North Am; 2022 Sep; 51(3):625-647. PubMed ID: 36153114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. JNETS clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms: diagnosis, treatment, and follow-up: a synopsis.
    Ito T; Masui T; Komoto I; Doi R; Osamura RY; Sakurai A; Ikeda M; Takano K; Igarashi H; Shimatsu A; Nakamura K; Nakamoto Y; Hijioka S; Morita K; Ishikawa Y; Ohike N; Kasajima A; Kushima R; Kojima M; Sasano H; Hirano S; Mizuno N; Aoki T; Aoki T; Ohtsuka T; Okumura T; Kimura Y; Kudo A; Konishi T; Matsumoto I; Kobayashi N; Fujimori N; Honma Y; Morizane C; Uchino S; Horiuchi K; Yamasaki M; Matsubayashi J; Sato Y; Sekiguchi M; Abe S; Okusaka T; Kida M; Kimura W; Tanaka M; Majima Y; Jensen RT; Hirata K; Imamura M; Uemoto S
    J Gastroenterol; 2021 Nov; 56(11):1033-1044. PubMed ID: 34586495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical, pathological and prognostic characteristics of gastroenteropancreatic neuroendocrine neoplasms in China: a retrospective study.
    Zhang X; Ma L; Bao H; Zhang J; Wang Z; Gong P
    BMC Endocr Disord; 2014 Jul; 14():54. PubMed ID: 25001493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastroenteropancreatic neuroendocrine neoplasms: a 10-year experience of a single center.
    Lewkowicz E; Trofimiuk-Müldner M; Wysocka K; Pach D; Kiełtyka A; Stefańska A; Sowa-Staszczak A; Tomaszewska R; Hubalewska-Dydejczyk A
    Pol Arch Med Wewn; 2015; 125(5):337-46. PubMed ID: 25924181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas.
    Garcia-Carbonero R; Sorbye H; Baudin E; Raymond E; Wiedenmann B; Niederle B; Sedlackova E; Toumpanakis C; Anlauf M; Cwikla JB; Caplin M; O'Toole D; Perren A;
    Neuroendocrinology; 2016; 103(2):186-94. PubMed ID: 26731334
    [No Abstract]   [Full Text] [Related]  

  • 13. An update on the diagnosis of gastroenteropancreatic neuroendocrine neoplasms.
    Fang JM; Li J; Shi J
    World J Gastroenterol; 2022 Mar; 28(10):1009-1023. PubMed ID: 35431496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history of gastro-entero-pancreatic and thoracic neuroendocrine tumors. Data from a large prospective and retrospective Italian epidemiological study: the NET management study.
    Faggiano A; Ferolla P; Grimaldi F; Campana D; Manzoni M; Davì MV; Bianchi A; Valcavi R; Papini E; Giuffrida D; Ferone D; Fanciulli G; Arnaldi G; Franchi GM; Francia G; Fasola G; Crinò L; Pontecorvi A; Tomassetti P; Colao A
    J Endocrinol Invest; 2012 Oct; 35(9):817-23. PubMed ID: 22080849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial impact of a systematic multidisciplinary approach on the management of patients with gastroenteropancreatic neuroendocrine tumor.
    Tamagno G; Sheahan K; Skehan SJ; Geoghegan JG; Fennelly D; Collins CD; Maguire D; Traynor O; Brophy DP; Cantwell C; Swan N; McGowan L; O'Toole D; O'Shea D
    Endocrine; 2013 Oct; 44(2):504-9. PubMed ID: 23471696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathologic characteristics and prognosis of gastroenteropancreatic neuroendocrine neoplasms: a multicenter study in South China.
    Fang C; Wang W; Zhang Y; Feng X; Sun J; Zeng Y; Chen Y; Li Y; Chen M; Zhou Z; Chen J
    Chin J Cancer; 2017 Jun; 36(1):51. PubMed ID: 28637502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastroenteropancreatic Neuroendocrine Neoplasms in Patients with Inflammatory Bowel Disease: An ECCO CONFER Multicentre Case Series.
    Festa S; Zerboni G; Derikx LAAP; Ribaldone DG; Dragoni G; Buskens C; van Dijkum EN; Pugliese D; Panzuto F; Krela-Kaźmierczak I; Mintz HR; Shitrit AB; Chaparro M; Gisbert JP; Kopylov U; Teich N; Vainer E; Nagtegaal I; Hoentjen F; Garcia MJ; Filip R; Foteinogiannopoulou K; Koutroubakis IE; Argollo M; van Wanrooij RLJ; Laja H; Lobaton T; Truyens M; Molnar T; Savarino E; Aratari A; Papi C; Goren I
    J Crohns Colitis; 2022 Jul; 16(6):940-945. PubMed ID: 34864927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiological Data and Treatment of Gastroenteropancreatic Neuroendocrine Neoplasms: Insights From Tertiary Referral Hospitals in Latvia.
    Ptasnuka M; Ozolins A; Narbuts Z; Truskovs A; Sperga M; Plaudis H
    World J Surg; 2020 Feb; 44(2):585-593. PubMed ID: 31605174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastroenteropancreatic neuroendocrine neoplasms: genes, therapies and models.
    Kawasaki K; Fujii M; Sato T
    Dis Model Mech; 2018 Feb; 11(2):. PubMed ID: 29590641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival of Patients With Gastroenteropancreatic Neuroendocrine Tumors and Diabetes Mellitus.
    Thapi S; Baeg K; Kim MK; Gallagher EJ
    Pancreas; 2021 Oct; 50(9):1293-1297. PubMed ID: 34860814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.